Role of Homoeopathy in Irritable Bowel Syndrome

Efficacy of Individualized Homoeopathic Medicines versus Asafoetida 30C in the management of Irritable Bowel Syndrome: A Single-Blind Randomized Controlled Trial - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/12/078667

Enrollment

Registered

2024-12-27

Start date

Unknown

Completion date

Unknown

Last updated

2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K582- Mixed irritable bowel syndrome

Interventions

Intervention1: Standard regimen (diet modification, lifestyle changes, stress management) plus individualized homoeopathic medicines.: Total 60 patients will be included in trial. Upon receiving patie

Eligibility

Inclusion criteria

Inclusion criteria: Score of more than 75 on Irritable Bowel Syndrome- Symptom severity scale (IBS-SSS). Patients giving written consent to participate in the study.

Exclusion criteria

Exclusion criteria: Patients with other severe systemic illnesses, malignant disorders, autoimmune diseases or any organic disease. Patients above 50 years of age. Any major surgery in the last 6 months. Patients under other medication for the same complaint. Patients with cognitive impairment. Pregnant women and lactating mothers. Patients who are already enrolled in some other study. Patients who are not willing to give the consent.

Design outcomes

Primary

Measure	Time frame
Irritable Bowel Syndrome-Symptom Severity Scale (IBS-SSS)Timepoint: At baseline and after 12 weeks of intervention	—

Secondary

Measure	Time frame
EQ-5D QuestionnaireTimepoint: At baseline and after 12 weeks of intervention	—

Countries

India

Contacts

Public ContactDr Prabhjeet Kaur

Nehru Homoeopathic Medical College and Hospital

drmohitmathur@gmail.com9818449588

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026